BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21417747)

  • 1. A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis.
    Bernstein IL; Bernstein DI; Lummus ZL; Bernstein JA
    J Womens Health (Larchmt); 2011 Apr; 20(4):643-8. PubMed ID: 21417747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogen Sensitization: a Unique Female Presentation of Anaphylaxis.
    Bernstein JA
    Curr Allergy Asthma Rep; 2020 Jan; 20(1):4. PubMed ID: 31993777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune Progesterone Dermatitis Diagnosed by Lymphocyte Transformation Test and Progesterone Provocation Test.
    Ljubojević Hadžavdić S; Marinović Kulišić S; Ljubojević Grgec D; Poljanac A; Ilić B
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):276-277. PubMed ID: 30390735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review.
    Snyder JL; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2003 May; 90(5):469-77; quiz 477, 571. PubMed ID: 12775127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune progesterone dermatitis: Case report with history of urticaria, petechiae and palpable pinpoint purpura triggered by medical abortion.
    Mbonile L
    S Afr Med J; 2016 Mar; 106(4):48-50. PubMed ID: 27032848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Progesterone Dermatitis: A Case Report.
    Özdemir Ö; Yahşi GG; Atalay CR
    Rev Bras Ginecol Obstet; 2019 Mar; 41(3):203-205. PubMed ID: 30939605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Back up contraception].
    Dacheva T
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune progesterone dermatitis: Case report of an unexpected treatment reaction.
    Camões S; Sampaio J; Rocha J; Tiago P; Lopes C
    Australas J Dermatol; 2017 Aug; 58(3):e132-e134. PubMed ID: 27489085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Escapelle - a method of choice for emergency contraception ].
    Tanchev L
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG.
    Beaumont JL; Lemort N
    Clin Exp Immunol; 1976 Jun; 24(3):455-63. PubMed ID: 820501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune progesterone dermatitis presenting as fixed drug eruption: a case report.
    Mokhtari R; Sepaskhah M; Aslani FS; Dastgheib L
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
    Grimes EM; Thompson IE; Taymor ME
    J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dermatitis caused by estrogens].
    Coustou D; Gautier C; Ducombs G; Barbaud A; Geniaux M
    Ann Dermatol Venereol; 1998 Aug; 125(8):505-8. PubMed ID: 9747316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
    Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
    Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
    Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emergency contraception ].
    Amaliev G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():19-24. PubMed ID: 19504703
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gingival recession during progesterone-estrogen therapy].
    Favero GA; Cordioli GP; Musajo F; Favero L
    G Stomatol Ortognatodonzia; 1982; 1(2):69-70. PubMed ID: 6964542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.